Quantification of P-Glycoprotein in the Gastrointestinal Tract of Humans and Rodents: Methodology, Gut Region, Sex, and Species Matter | Molecular Pharmaceutics
![Life | Free Full-Text | Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment Life | Free Full-Text | Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment](https://pub.mdpi-res.com/life/life-12-00029/article_deploy/html/images/life-12-00029-g001.png?1640431486)
Life | Free Full-Text | Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment
![Dr. Hector P. Garcia, founder of the American G.I. Forum, received the Presidential Medal of Freedom, Dr. Hector P. Garcia, founder of the American G.I. Forum, received the Presidential Medal of Freedom,](https://media.defense.gov/2007/Mar/14/2001087179/1088/820/0/062622-H-YGR38-240.jpg)
Dr. Hector P. Garcia, founder of the American G.I. Forum, received the Presidential Medal of Freedom,
![Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0079610711000812-gr2.jpg)
Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect
![IJMS | Free Full-Text | GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease–A Systematic Review IJMS | Free Full-Text | GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease–A Systematic Review](https://www.mdpi.com/ijms/ijms-21-01509/article_deploy/html/images/ijms-21-01509-g001.png)
IJMS | Free Full-Text | GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease–A Systematic Review
![GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells | Science Advances GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells | Science Advances](https://www.science.org/cms/10.1126/sciadv.abf1948/asset/81121dd8-a105-47ab-b263-f658ea8714d0/assets/graphic/abf1948-f6.jpeg)
GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells | Science Advances
![Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents - ScienceDirect Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0196978117303674-fx1.jpg)
Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents - ScienceDirect
![The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library](https://dom-pubs.onlinelibrary.wiley.com/cms/asset/4d065d23-33ad-42b7-bfbc-8a244219872f/dom14496-fig-0004-m.jpg)
The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library
![Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0079610711000812-gr3.jpg)
Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect
![The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology | Full Text The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-021-01412-5/MediaObjects/12933_2021_1412_Fig1_HTML.png)
The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology | Full Text
![Total Glucose-dependent Insulinotropic Peptide (GIP) ELISA, 27203 (RUO) | Human Total GIP (Gastric Inhibitory Polypeptide) Competitive Enzyme-linked Immune-sorbent Assay Kit IBL-America Total Glucose-dependent Insulinotropic Peptide (GIP) ELISA, 27203 (RUO) | Human Total GIP (Gastric Inhibitory Polypeptide) Competitive Enzyme-linked Immune-sorbent Assay Kit IBL-America](https://cdn11.bigcommerce.com/s-dpaty9ionu/images/stencil/1280x1280/products/5808/13955/pancreas2__49390.1635962302.png?c=2)